Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Goebeler M, Bata-Csorgo Z, De Simone C, Didona B, et al. Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase 2 multicentre, open-label feasibility trial. Br J Dermatol 2021 Oct 5. doi: 10.1111/bjd.20782.
PMID: 34608631


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016